|Rapid Review Complete
|For the symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief.
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Full Pharmacoeconomic Evaluation not Recommended
Prucalopride (Resolor®) is to be reimbursed under the Community Drugs Schemes subject to conditions.